Evidence map›Paper›PMID 36558047›Full record

ArticleMolecules (Basel, Switzerland)2022

Development of a Protein-Rich By-Product by 2

Thamara R Dos Santos, Jakcline Dos Santos Melo, Alysson V Dos Santos, Patrícia Severino, Álvaro S Lima, Eliana B Souto, Aleksandra Zielińska, Juliana C Cardoso

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thamara R Dos SantosDepartment of Pharmacy, Tiradentes University (UNIT), Murilo Dantas Ave. 300, Farolândia, Aracaju 49032-490, SE, Brazil.
Jakcline Dos Santos MeloDepartment of Pharmacy, Tiradentes University (UNIT), Murilo Dantas Ave. 300, Farolândia, Aracaju 49032-490, SE, Brazil.
Alysson V Dos SantosPost-Graduation Program in Process Engineering, Tiradentes University (UNIT), Murilo Dantas Ave. 300, Farolândia, Aracaju 49032-490, SE, Brazil.
Patrícia SeverinoDepartment of Pharmacy, Tiradentes University (UNIT), Murilo Dantas Ave. 300, Farolândia, Aracaju 49032-490, SE, Brazil.ORCID 0000-0001-6527-6612
Álvaro S LimaPost-Graduation Program in Process Engineering, Tiradentes University (UNIT), Murilo Dantas Ave. 300, Farolândia, Aracaju 49032-490, SE, Brazil.
Eliana B SoutoDepartment of Pharmaceutical Technology, Faculty of Pharmacy of University of Porto, Rua Jorge de Viterbo Ferreira, 228, 4050-313 Porto, Portugal.ORCID 0000-0002-9737-6017
Aleksandra ZielińskaInstitute of Human Genetics, Polish Academy of Sciences, Strzeszyńska 32, 60-479 Poznań, Poland.
Juliana C CardosoDepartment of Pharmacy, Tiradentes University (UNIT), Murilo Dantas Ave. 300, Farolândia, Aracaju 49032-490, SE, Brazil.ORCID 0000-0002-0357-4144

Funding

Banco do Nordeste (BNB), Coordenação Aperfeiçoamento de Pessoal de Nivel Superior (CAPES), Fundação de Amparo à Pesquisa do Estado de Sergipe (FAPITEC) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 2022Foundation for Polish Science (FNP) START 2021 ProgramNational Science Centre in Poland within the MINIATURA-4 2020/04/X/ST5/00789
6 · The paper itself

Abstract

The aim of this study was the development of a cereal bar based on bee pollen (BP), honey (H), and flour by-products (peel passion fruit flour-PPFF), generating an innovative product. BP is a protein-rich ingredient and can be used in the composition of cereal bars. PPFF is a by-product rich in fibers. The formulations were developed using a 2

Indexed as

Dietary FiberHoneyEdible GrainNutritive ValueDietary Fiberbee pollenexperimental factorial designfood technologyhoneyprotein-rich by-productsensory analysis

Identifiers

PMID36558047
PMCPMC9783521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.